{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:03Z","timestamp":1786980483725,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10067-020-05053-z","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T12:36:57Z","timestamp":1585831017000},"page":"2999-3007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Higher risk of Parkinson disease in patients with primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"39","author":[{"given":"Hui-Ching","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Yun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-I","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"5053_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jns.2013.12.014","volume":"338","author":"S Kapoor","year":"2014","unstructured":"Kapoor S (2014) Parkinsonism: an under-recognized neurological complication of Sjogren's syndrome. J Neurol Sci 338:235. https:\/\/doi.org\/10.1016\/j.jns.2013.12.014","journal-title":"J Neurol Sci"},{"key":"5053_CR2","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"5053_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(09)70062-6","journal-title":"Lancet Neurol"},{"key":"5053_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"5053_CR5","doi-asserted-by":"publisher","first-page":"e000179","DOI":"10.1136\/rmdopen-2015-000179","volume":"2","author":"G Carvajal Alegria","year":"2016","unstructured":"Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A (2016) Epidemiology of neurological manifestations in Sjogren's syndrome: data from the French ASSESS Cohort. RMD Open 2:e000179. https:\/\/doi.org\/10.1136\/rmdopen-2015-000179","journal-title":"RMD Open"},{"key":"5053_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0303-8467(93)90009-6","volume":"95","author":"LH Visser","year":"1993","unstructured":"Visser LH, Koudstaal PJ, van de Merwe JP (1993) Hemiparkinsonism in a patient with primary Sjogren's syndrome. A case report and a review of the literature. Clin Neurol Neurosurg 95:141\u2013145","journal-title":"Clin Neurol Neurosurg"},{"key":"5053_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/7854_2014_356","volume":"22","author":"C Cebrian","year":"2015","unstructured":"Cebrian C, Loike JD, Sulzer D (2015) Neuroinflammation in Parkinson's disease animal models: a cell stress response or a step in neurodegeneration? Curr Top Behav Neurosci 22:237\u2013270. https:\/\/doi.org\/10.1007\/7854_2014_356","journal-title":"Curr Top Behav Neurosci"},{"key":"5053_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74:995\u20131002. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5a4a3","journal-title":"Neurology"},{"key":"5053_CR9","doi-asserted-by":"publisher","first-page":"628192","DOI":"10.1155\/2015\/628192","volume":"2015","author":"NP Rocha","year":"2015","unstructured":"Rocha NP, de Miranda AS, Teixeira AL (2015) Insights into neuroinflammation in Parkinson's disease: from biomarkers to anti-inflammatory based therapies. Biomed Res Int 2015:628192. https:\/\/doi.org\/10.1155\/2015\/628192","journal-title":"Biomed Res Int"},{"key":"5053_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12035-014-8769-7","volume":"51","author":"P Thakur","year":"2015","unstructured":"Thakur P, Nehru B (2015) Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson's disease. Mol Neurobiol 51:209\u2013219. https:\/\/doi.org\/10.1007\/s12035-014-8769-7","journal-title":"Mol Neurobiol"},{"key":"5053_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175836","volume":"12","author":"MC Wu","year":"2017","unstructured":"Wu MC, Xu X, Chen SM, Tyan YS, Chiou JY, Wang YH, Lin LC, Chen CM, Wei JC (2017) Impact of Sjogren's syndrome on Parkinson's disease: a nationwide case-control study. PLoS One 12:e0175836. https:\/\/doi.org\/10.1371\/journal.pone.0175836","journal-title":"PLoS One"},{"key":"5053_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","volume":"50","author":"CC Chang","year":"2018","unstructured":"Chang CC, Lin TM, Chang YS, Chen WS, Sheu JJ, Chen YH, Chen JH (2018) Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan. Ann Med 50:83\u201390. https:\/\/doi.org\/10.1080\/07853890.2017.1412088","journal-title":"Ann Med"},{"key":"5053_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MD.0000000000014984","volume":"98","author":"UH Ju","year":"2019","unstructured":"Ju UH, Liu FC, Lin CS, Wen-Yen Huang WY et al (2019) Risk of Parkinson disease in Sj\u00f6gren syndrome administered ineffective immunosuppressant therapies: a nationwide population-based study. Medicine 98:14. https:\/\/doi.org\/10.1097\/MD.0000000000014984","journal-title":"Medicine"},{"key":"5053_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1377\/hlthaff.2014.1332","volume":"34","author":"TM Cheng","year":"2015","unstructured":"Cheng TM (2015) Reflections on the 20th anniversary of Taiwan's single-payer National Health Insurance System. Health Aff (Millwood) 34:502\u2013510. https:\/\/doi.org\/10.1377\/hlthaff.2014.1332","journal-title":"Health Aff (Millwood)"},{"key":"5053_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3899\/jrheum.100883","volume":"38","author":"MY Weng","year":"2011","unstructured":"Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study. J Rheumatol 38:706\u2013708. https:\/\/doi.org\/10.3899\/jrheum.100883","journal-title":"J Rheumatol"},{"key":"5053_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","volume":"81","author":"M Garcia-Carrasco","year":"2002","unstructured":"Garcia-Carrasco M et al (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81:270\u2013280","journal-title":"Medicine (Baltimore)"},{"key":"5053_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.semarthrit.2004.07.005","volume":"34","author":"K Morgen","year":"2004","unstructured":"Morgen K, McFarland HF, Pillemer SR (2004) Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 34:623\u2013630","journal-title":"Semin Arthritis Rheum"},{"key":"5053_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10067-006-0398-8","volume":"26","author":"S Hassin-Baer","year":"2007","unstructured":"Hassin-Baer S, Levy Y, Langevitz P, Nakar S, Ehrenfeld M (2007) Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism. Clin Rheumatol 26:743\u2013747. https:\/\/doi.org\/10.1007\/s10067-006-0398-8","journal-title":"Clin Rheumatol"},{"key":"5053_CR19","first-page":"1009","volume":"26","author":"S Kobayashi","year":"1986","unstructured":"Kobayashi S, Yamaguchi S, Suzuki T, Yamauchi K, Tsunematsu T (1986) Central nervous system involvement in primary Sjogren's syndrome. Rinsho Shinkeigaku 26:1009\u20131016","journal-title":"Rinsho Shinkeigaku"},{"key":"5053_CR20","first-page":"57","volume":"37","author":"H Mochizuki","year":"1997","unstructured":"Mochizuki H, Okano M, Masaki T, Nagata N, Kamakura K (1997) A case of Sjogren's syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism. Rinsho Shinkeigaku 37:57\u201359","journal-title":"Rinsho Shinkeigaku"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-05053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T19:52:06Z","timestamp":1617306726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-05053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5053"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05053-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}